Thai Health Experts Get WHO Help To Overcome Vaccine Delay
This article was originally published in PharmAsia News
Executive Summary
Thailand's Government Pharmaceutical Organization says the World Health Organization is helping it deal with problems in developing an H1N1 flu vaccine. The Thai effort has encountered a hurdle in obtaining more than a low yield from the viruses it has been growing in eggs. The WHO is conferring with the GPO and the Public Health Ministry on how to improve the yield. The first trial of a vaccine in Thailand, originally scheduled to begin Sept. 4, now faces a two-month delay because of the problems. (Click here for more
You may also be interested in...
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.